O
ONI
Manufacturer of the next generation of super-resolution microscopes
About ONI
ONI is a biotechnology company that has developed and commercialized a desktop super-resolution microscope, the Nanoimager, which allows for the visualization and tracking of individual molecules in living cells.
Read full description
The company's technology is based on a technique called direct Stochastic Optical Reconstruction Microscopy (dSTORM), which enables imaging at a resolution of 20nm. The Nanoimager is a compact and easy-to-use instrument that is designed to be accessible to a broad range of researchers. ONI also offers the Aplo Scope, which combines high-power SMLM imaging with low-power live-cell imaging.
ONI operates in the life sciences and biotechnology markets, serving academic and industrial researchers in fields such as cell biology, immunology, and virology. The company's business model is based on the sale of its microscope instruments, as well as consumables and services. ONI was spun out of Oxford University in 2016 and is headquartered in Oxford, UK, with an office in San Diego, CA.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Oxford, United Kingdom
- Employees
- 199
- Open positions
- None listed
- Dealroom signal
- 73.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Molecular Biology, Spinout, Microscope, Tech for Biotech and Pharma, Tech for Hospitals and Clinics
- Technology
- Hardware, Deep Tech, Nanotech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning ONI.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jan 2022 | $75M | $300M | Casdin Capital · ARCH Venture Partners · Axon Ventures · Oxford Science Enterprises | ↗ |
| SERIES AOther financing | Mar 2018 | $24M | $96M | Casdin Capital · Oxford Science Enterprises | — |
Growth signals
Latest recorded traffic for ONI is 47K monthly website visits, up 213.3% over the last three months. ONI's team grew 2.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Oxford Science Enterprises
GT Healthcare
Series A7 investors entered at this stage
Casdin Capital
ARCH Venture Partners
Axon Ventures- PCPaul Conley
Artis Ventures
Section 32
Vertical Venture Partners
Other known investors2 additional known investors
Oxford University Innovation
University of Oxford
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ONI on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ONI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.